Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Cetuximab (C225) and Pemetrexed With Concurrent Radiation in Head and Neck Cancer

NCT00291707 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00291707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00291707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Cetuximab (C225) and Pemetrexed With Concurrent Radiation in Head and Neck Cancer
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2006
Completion date
January 31, 2009
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer